Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SERA PROGNOSTICS, INC. | Director | Class A Common Stock | 6.64K | $47.2K | $7.12 | Dec 6, 2024 | Direct |
Karyopharm Therapeutics Inc. | Director | Nonstatutory Stock Option (right to buy) | 69K | May 29, 2024 | Direct | ||
SERA PROGNOSTICS, INC. | Director | Stock Option (right to buy) | 10.5K | Jun 6, 2024 | Direct |